KIR2DL1 Antibody

1. KIR 2D (L1, L3, L4, S4) and KIR 3DL1 expression was correlated with poor prognosis in non-small cell lung carcinoma patients. PMID:27893413
2. A negative association between the KIR2DL1 polymorphism and susceptibility to type 1 diabetes mellitus was found. PMID:29384924
3. the surface organization of paired killer Ig-like receptors (KIR), KIR2DL1 and KIR2DS1, on human primary natural killer cells and cell lines, was examined. PMID:27210755
4. A significantly higher risk of chronic rejection after kidney transplantation was observed when recipient (r) and donor (d) pairs completely lacked the two functional rKIR-dHLA ligand combinations rKIR2DL1/dHLA-C2 and rKIR3DL1/dHLA-Bw4. PMID:28686681
5. CD16+ cells were significantly more frequent among Natural Killer (NK) cells negative for the inhibitory KIR (iKIR) KIR2DL1, KIR2DL3, and KIR3DL1 than those positive for any one of these iKIR to the exclusion of the others, making iKIR+ NK cells poorer antibody dependent cellular cytotoxicity effectors than iKIR- NK cells. PMID:27732638
6. Data indicate that a novel variant allele, KIR2DL1*031, was identified by cDNA cloning and haplotype sequencing of killer cell immunoglobulin-like receptor 2DL1 (KIR2DL1) gene. PMID:27577226
7. KIR2DL1-C2C2 is less frequent in type 1 diabetes in Saudi children PMID:26542066
8. Influence of Differently Licensed KIR2DL1-Positive Natural Killer Cells in Transplant Recipients with Acute Leukemia PMID:26456260
9. Educated natural killer cells expressing KIR2DL1 display functional advantage for anti-HIV-1 antibody-dependent activation. PMID:26647083
10. KIR2DL1*022 and 2DL1*026 evolved in the KhoeSan after their divergence from other modern human populations. PMID:26292085
11. Data suggest regulatory interactions between major histocompatibility antigen HLA-C and killer cell Ig-like receptor (KIR) might promote Graft-versus-Leukemia effects following transplantation. PMID:26416275
12. Coengagement of inhibitory receptors, either KIR2DL1 or CD94-NKG2A, did not inhibit phosphorylation of Stat5 but inhibited selectively phosphorylation of Akt and S6 ribosomal protein. PMID:26453750
13. genetic association studies in Chinese Han population: Data suggest that the frequency of KIR2DL1 gene is increased in women with pre-eclampsia when homozygous HLA-C2 allele appears in the fetus. PMID:24951171
14. Array CGH showed a 95 Kb de novo duplication on chromosome 19q13.4 encompassing four killer cell immunoglobulin-like receptor (KIR) genes. PMID:23952617
15. These results revealed that ITIM phosphorylation is controlled by self-association of KIR and that His-36 serves as a gatekeeper to prevent unregulated signaling through KIR2DL1. PMID:25505289
16. C2 of KIR2DL1 is a novel risk factor, and homozygosity for C1 is a protective factor for childhood B-ALL PMID:25163702
17. We investigated the association of HLA alleles and KIR ligands according to oligoclonal band status in multiple sclerosis patients. PMID:25037176
18. Our findings suggest KIR2DL1(+)-HLA-C2(+) genotype as heritable risk factor in oral squamous cell carcinoma (OSCC) predisposing to OSCC at a younger age. PMID:24818561
19. Normal NK CD158a expression is associated with successful IVF and pregnancy. PMID:23951916
20. Donor KIR2DL1 allelic polymorphism affects recipient outcomes after allogeneic hematopoietic stemm cell transplantation. PMID:24043749
21. Data indicate that positive linkage disequilibrium was observed between KIR3DL1, 2DL1, 2DL3 and 2DS4 which is consistent with the associations between the constituents of A haplotypes. PMID:23354323
22. NK cells were isolated from peripheral blood and the lysis of KG1A and K562 cells by the NK cells was analyzed to investigate whether KIR2DL1 expression on NK cells would affect the cytotoxicity. PMID:23865361
23. cytomegalovirus positive had lower proportions of NK-cells expressing inhibitory receptors (KLRG1 and CD158a) PMID:21933704
24. DNA-demethylating treatment with 5-azacytidine resulted in re-expression of kir2DL1 gene and increased expressions of kir2DL1, kir2DL2 and kir2DL3 genes in NK-92MI cells. PMID:19549382
25. Results demonstrate that receptor-ligand dimensions, NKG2D/MICA and KIR2DL1/HLA-C, are important in NK cell recognition. PMID:21179506
26. supervillin is a novel molecule that associates with KIR2DL1 receptor and regulates the inhibitory signaling in NK cells. PMID:21070852
27. Inhibitory receptor KIR2DL1 in combination with HLA-C2 ligand confers susceptibility to chronic hepatitis B (CHB), whereas inhibitory receptor KIR2DL3 or KIR2DL3 homozygote in the presence of HLA-C1C1 genotype shows protection against CHB. PMID:20643584
28. Results suggest a protective role of KIR2DL1/C2 in T1D. PMID:20580654
29. Eleven new KIR2DL1 alleles were identified by DNA sequencing of the coding region from amplified genomic DNA from 100 random African Americans PMID:20210923
30. The KIR2DL1 gene polymorphism and KIR/HLA-C gene compatibility are associated with type 1 diabetes. PMID:20356536
31. Data show that KIR activation and HLA expression density are critical determinants for the efficacy of rituximab treatment. PMID:20056126
32. study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL PMID:19450876
33. Contrary to CD158a and CD158b killer immunoglobulin-like receptors (KIRs), there is a significant positive correlation of NKG2D and CD161 expression with NK cytotoxicity. PMID:19711124
34. interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction PMID:12351398
35. The engagement of the activating isoforms of killer Ig-like receptor (KIR)(CD158a or CD158b) by their natural ligands, represented by soluble HLA-I molecules, induced programmed cell death of natural killer cells PMID:12393468
36. Positive linkage disequilibrium was seen between KRI2DL1 and KIR2DL3. PMID:12559621
37. The unique property of KIR2DL1 to become phosphorylated in the absence of adhesion and actin cytoskeleton rearrangement explains how KIRs can efficiently block early activation signals during NK-target cell contacts. PMID:12794140
38. Increased binding to influenza virus-infected cells is observed in the killer cell Ig-like receptor 2 domain long tail 1, binding that is functional and possibly results from generation of complexes of class I MHC proteins after influenza virus infection. PMID:12847262
39. A significant decrease in NK cell CD158a expression was demonstrated in recurrent spontaneous abortion women PMID:15209394
40. KIR2DS1 and KIR2DL1 share sensitivity to peptide sequence alterations. These results fit a model in which activating and inhibitory receptors recognize the same sets of self-MHC class I molecules, differing only in their binding affinities. PMID:16141329
41. Posttranslational modifications such as phosphorylation of a presented KIR2DL peptide alters the ability of natural killer (NK) cells to recognize MHC class I molecule HLA-Cw4, and results in improved NK cell killing. PMID:16709835
42. This is a new killer immunoglobulin-like receptor allele. PMID:16774543
43. alleles 2DL1*00302 and *002 were frequently observed in addition to two other known alleles and four new alleles, 2DL1*00402, 2DL1*007, 2DL1*008, and 2DL1*009 in three families and 77 bone marrow transplant patients and donors PMID:17493149
44. Data show that there was no correlation between CD15ab expression and disease activity in rheumatoid arthritis. PMID:17497034
45. CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sezary syndrome PMID:17522341
46. KIR2DL1 may induce 2 opposite signaling outputs in CD4(+) T cells, depending on whether the KIR receptor is bound to its ligand. PMID:18574028
47. The role of this investigation has been to create a base of genetic information in relation to both KIR2DL1 and KIR2DS1 allele diversity. PMID:18643963
48. Findings provide novel insights into the molecular determinant of KIR2DL1 and conceivably a fundamental understanding of KIR2DL1 allelic polymorphism in human disease susceptibility, transplant outcome, and donor selection. PMID:19828694

Show More

Hide All

HGNC: 6329

UNIGENE: Hs.654605

KEGG: hsa:3802

STRING: 9606.ENSP00000336769

OMIM: 604936